Hence, given that the mRNA and protein level of BDNF is significantly reduced in the substantia nigra of postmortem brain tissue obtained from PD humans [65, 177], targeting the BDNF signaling pathway has emerged as a potential therapeutic option to enhance mitochondrial respiration [80, 178, 179]. Here, BDNF is linked to Parkinson disease.